IAC vs IRDM

IAC presents a contradictory profile characterized by a very weak Piotroski F-Score of 2/9, indicating deteriorating operational health, contrasted by a strong liquidity position and deep value valuation. While the company trades at a significant discount to book value (P/B 0.67), it is struggling with negative revenue growth (-10.5% YoY) and highly volatile earnings. The balance sheet remains healthy with low debt/equity (0.34) and a strong current ratio (2.75), providing a safety buffer despite operational headwinds. The overall outlook is neutral as the deep value is offset by shrinking top-line growth and poor fundamental health scores.

IRDM exhibits a severe disconnect between its current market price ($34.20) and its deterministic value markers, with a Graham Number of $10.25 and an Intrinsic Value of $7.42. While the Piotroski F-Score of 6/9 indicates stable financial health, this is offset by stagnant revenue growth (0.00%) and a significant decline in earnings (-24.20% YoY). The stock is trading at a massive premium (P/B of 7.76) despite a bearish technical trend and negative insider sentiment. The recent price surge appears speculative as it is not supported by fundamental growth or analyst target prices ($30.38).